Posted On: 10/28/2015 11:35:05 PM
Post# of 72446
AVXL is tackling neurological diseases- these are often hard and difficult diseases to treat, most drugs in the market only treat the symptoms .
I know Anavex is using a different pathway but I don't have enough knowledge to understand the nitty gritty of the supposed pathway they're addressing.
Anyway, good luck to those holding the stocks of this company. I just feel annoyed that people are bringing up this company as comparison because they're comparing apple to orange.
Both companies maybe biotech but they're addressing different disease markets and hence, have different risk profile- I do think AVXL is a lot riskier than CTIX.
I know Anavex is using a different pathway but I don't have enough knowledge to understand the nitty gritty of the supposed pathway they're addressing.
Anyway, good luck to those holding the stocks of this company. I just feel annoyed that people are bringing up this company as comparison because they're comparing apple to orange.
Both companies maybe biotech but they're addressing different disease markets and hence, have different risk profile- I do think AVXL is a lot riskier than CTIX.
(0)
(0)
